Bethesda, MD (PRWEB) May 31, 2013
Novel Health Strategies, a leading life sciences consulting firm, is presenting studies at the Health Technology Assessment (HTAi) 2013 Annual Meeting in Seoul, South Korea on market access strategy, pricing and health economic and outcomes research trends. The following two studies will be presented by NOVEL's team:
1. Impact of New Policy Changes on Need for Pharmacoeconomic Evidence for Reimbursement and Market Access
This study analyzed global healthcare reforms in developed and emerging markets, and assessed their impact on pricing and market access of medical products.
Abstract no. is 1322.
2. Trends in Use of Health Economic Evidence for Developing Clinical Guidelines' at HTAi 2013
This study analyzed global trends in use of health economic (HE) evidence by clinical guidelines. The results of this study show an increasing trend in citation, reference and use of HE data by medical societies.
Abstract no. is 1321.
About Novel Health Strategies
Novel Health Strategies ("NOVEL") is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access. NOVEL's team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. NOVEL has a large network of internal and external stakeholders and has published several thought leading strategy perspectives. NOVEL has presented industry trends and perspectives at ISPOR, AMCP and BIO meetings.